ProPhase Labs, Inc. (PRPH) Stock

ProPhase Labs, Inc. is a prominent player in the United States specializing in the research, development, manufacturing, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements. The company operates through two key segments: Diagnostic Services and Consumer Products. Its extensive portfolio includes a variety of OTC dietary supplements, notably Legendz XL for male sexual health and Triple Edge XL, an energy and stamina booster, catering to a wide consumer base.

In addition to its consumer products, ProPhase Labs offers comprehensive contract manufacturing services encompassing product development, pre-commercialization, production, warehousing, and distribution. The company has also ventured into diagnostic services, providing SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction (PCR) tests using both saliva and nasal swab methods, alongside other respiratory pathogen panel molecular testing services. Moreover, ProPhase Labs offers personal genomics products and services, enhancing its position in the healthcare industry.

Established in 1989 and originally known as The Quigley Corporation, ProPhase Labs, Inc. is headquartered in Garden City, New York. It serves a diverse clientele including national chain drugstores, internet-based retailers, and various regional outlets, maintaining a strong foothold in the competitive OTC consumer healthcare market.